Web Images Videos Maps News Shopping Gmail more »
Sign in
Go to Blog Search Home

  
  Advanced Blog Search
  Preferences
 Blog resultsResults 1 - 10 of about 1,035 for taxotere patent. (0.23 seconds) 
Browse Top Stories
Published
Anytime

Subscribe:
Blogs Alerts Blogs Alerts
Atom | RSS
Sorted by relevance    Sort by date
 
2010 Products and Therapy Areas to Watch - Pharmaceutical Executive
3 Dec 2009
Over $15.7 billion of prescription drugs will be subject to generic competition in 2010 as a number of significant products come off patent. These include patent expiries for Aricept, Flomax, Taxotere, Effexor XR, Cozaar and Arimidex. ...
Pharmaceutical Executive Magazine - http://pharmexec.findpharma.com/pharmexec
[ More results from Pharmaceutical Executive Magazine ]

Pharma & Biotech Global Week in Review 9 Dec 09 from IP Think Tank ...
9 Dec 2009 by ( ))  
Surfaxin (Lucinactant) – US: PTO rules on the availability of multiple interim patent extensions (FDA Law Blog). Taxotere (Docetaxel) – Canada: Federal Court refuses to grant Order of Prohibition against Hospira regarding Docetaxel ...
Duncan Bucknell's site updates - http://duncanbucknell.com/ipthinktank.blog
[ More results from Duncan Bucknell's site updates ]

Sanofi profits soar, prepared for Plavix, Taxotere patent losses
29 Jul 2009
Sanofi-Aventis has posted a strong set of figures for the second quarter this morning and says it has laid the groundwork to cope with patent expiries.
PharmaTimes World News - http://www.pharmatimes.com/

Generic Taxotere
15 Jun 2007
A patent prevents any generic Taxotere from being manufactured at this time. This eMedTV page explains that May 2010 is the earliest date that a generic Taxotere could become available, unless certain circumstances (such as lawsuits) ...
eMedTV Breast Cancer Articles - http://breast-cancer.emedtv.com/

IP Think Tank Global Week in Review - 15 August 2008 (IP Think ...
15 Aug 2008 by duncan@duncanbucknell.com (Duncan Bucknell)  
1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on 'Development and IP: Building synergies with policy makers and industry' – Goa: (Patent ...
Duncan Bucknell's site updates - http://duncanbucknell.com/blog

two landmark studies of taxotere(reg) in prostate cancer ...
21 Jul 2009 by listburden  
aventis announced today that two landmark phase iii studies of taxotere (docetaxel) injection concentrate in men with androgen-independent (hormone-refractory) metastatic prostate cancer fool been selected for presentation at the ...
listburden - http://saturation.se/listburden/

celexa info
17 Dec 2009 by icergoreilt  
arava interaction with taxotere bone necrosis actonel advair diskus advair does diflucan have nickel in it arava and hair changes albuterol sulfate illicit georgia accutane lawsuits is albuterol a steroid bula amoxil bd ...
Warez Centre - http://warezcentre.org/

Patent Docs: Court Report
30 Aug 2009 by Patent Docs  
... 1998) following a Paragraph IV certification as part of Sun's filing of an NDA (under § 505(b)(2) of the Food, Drug and Cosmetic Act) to manufacture a generic version of Aventis' Taxotere® (docetaxel, used to treat breast, lung, prostate, ... Infringement of U.S. Patent No. 6107023 ("DNA Amplification and Subtraction Techniques," issued August 22, 2000) based on Illumina's manufacture and sale of products and associated instrumentation for use in Illumina's Genome ...
Patent Docs - http://www.patentdocs.org/ - References
[ More results from Patent Docs ]

Taxotere improves survival in advanced prostate cancer - The ...
27 Feb 2007 by Kristina Collins  
The thrust to identify an on-patent therapy which is microscopically better in clinical trials of one-size-fits-all (or roll-the-dice) treatment. It's not that every patients survival improves 21%. Some patients win the lottery and have ...
The Cancer Blog - http://www.thecancerblog.com/ - References

Cancerous disease modifying antibodies invention
11 Jun 2008
TAXOTERE® is the only FDA approved chemotherapy for the second line treatment of lung cancer. Initial data indicate an improved overall survival compared to TAXOTERE® alone. Out of the 62 patients who were recruited for the study, ... Information published here is for research/educational purposes only (and in conjunction with our Keyword Monitor) and is not meant to be used in place of the full USPTO patent document/images or a comprehensive patent archive search. ...
FreshPatents.com: Notable Patent Applications... - http://www.freshpatents.com/
[ More results from FreshPatents.com: Notable Patent Applications... ]

Stay up to date on these results:




 
  

Google Home - About Google Blog Search Beta - Information for Blog Authors

©2009 Google